|
Back to Index
What price a CD4 test?
PlusNews
May 07, 2009
http://www.plusnews.org/report.aspx?ReportID=84274
At the Opportunistic
Infections Clinic at Parirenyatwa Hospital, the largest referral
facility in Harare, capital of Zimbabwe, a group of 30 HIV-positive
patients are having the first of four counselling sessions on staying
healthy by eating a balanced diet, disclosing to family members
and avoiding cigarettes and alcohol.
Counselling is a requirement
for starting antiretroviral (ARV) treatment; the results from a
number of tests, none of which can be done at the hospital any more,
are also necessary.
Health workers, faced
with a lack of equipment, drugs and salaries as a result of Zimbabwe's
political and economic meltdown, went on strike towards the end
of 2008, forcing most hospitals to close for several months.
Under the new unity government,
most have returned to work, but Amon Siveregi, head of the Zimbabwe
Health Workers Association and a doctor at Parirenyatwa, said: "In
every department, there is still machinery that's not working."
A CD4 count machine,
which determines the strength of the immune system and readiness
to begin taking ARVs, has been broken for several months; equipment
for monitoring liver function and the amount of HI-virus in the
blood is also out of order.
Miriam Murema*, 39, has
completed the counselling sessions, but regularly scrapes together
bus fare and comes to the hospital, hoping the CD4 count machine
has been fixed. She last had a CD4 count in 2007, when it was 248,
but she has since lost weight and has a urinary infection. By now,
her CD4 count is almost certainly below 200, which would qualify
her for free treatment.
Murema was referred to
Harare Hospital, the only public health facility in Harare with
a working CD4 count machine, but, like several other patients IRIN/PlusNews
spoke to, because she was not registered as a patient there, she
was turned away.
She is now selling vegetables
to raise the money to pay for a CD4 count in the private sector.
"So far I've saved US$10," she told IRIN/PlusNews. "I
need US$20 more."
The few public and mission
hospitals that have the equipment charge between US$5 and US$10
for doing a CD4 count, but some also require a liver function test
and full blood count, which patients must also pay for.
Fees in the public sector
are much cheaper than the private sector, but Zimbabwe's long period
of hyperinflation and an unemployment rate above 80 percent mean
many people cannot afford them.
After travelling 25km
from her home to Parirenyatwa Hospital six times without being able
to get a CD4 test, Susan Tsoka* finally raised the US$30 to pay
for one at a private clinic. Emaciated and unable to speak above
a whisper, her result showed she had a CD4 count of 3. Now, finally,
she can see a doctor but with such a dangerously weak immune system,
ARV treatment may come too late.
Dr George Vera, the clinical
director of Harare Hospital, said there was no official policy of
turning away patients referred from other hospitals, but the laboratory
was short-staffed and needed to ensure an adequate supply of the
chemicals necessary to do the tests.
He pointed out that the
health department's protocol for starting patients on ARVs did not
require a CD4 count. Health Minister Dr Henry Madzorera confirmed
that patients at stage three or four of the disease, determined
by observable symptoms defined by the World Health Organization
(WHO), should be started on ARVs without a CD4 test.
"There are some
doctors who are very idealistic in their thinking, but we're not
living in an ideal world," Madzorera told IRIN/PlusNews. "CD4
counts have become very expensive and we're encouraging doctors
to use WHO criteria."
Ironically, if Murema
had gone to a rural hospital for treatment she may have faced fewer
obstacles. Mutoko Rural District Hospital, two hours' drive northeast
of Harare, has never had a CD4 count machine, but has started 1,250
patients on ARVs since 2006.
"We were told a
CD4 count machine was to come, but it never did," said Kembo
Chenjerai, a counsellor at the hospital's one-room opportunistic
infections clinic. "Mainly we rely on WHO staging."
Although this is not
ideal - "someone might look like they're at stage one
and be dead the next week," Chenjerai said - patients
can be tested for HIV and start taking ARVs almost immediately if
necessary.
Naume Rinomota, 53, a
widow who lives with her brother on a resettled farm, tested HIV
positive two weeks ago and is already taking ARVs and experiencing
less headaches and pain in her joints.
*Not their
real names
Please credit www.kubatana.net if you make use of material from this website.
This work is licensed under a Creative Commons License unless stated otherwise.
TOP
|